NewMarket
NEU
905.83
-20.45
-2.21%
NewMarket
US · NEU
#1616 by market cap
Listed 1970
905.83
-20.45
-2.21%
Live - 5344 symbols - heartbeat 494s ago
· 2026-10-08 05:23
Pre-market
905.50
-0.04%
After-hours
905.83
0.00%
- Market cap
- 8.33B
- P/E (TTM)i
- 19.49
- P/Bi
- 4.53
- EPSi
- 44.44
- Div yieldi
- 1.30%
- 52W posi
- 82%
Reader sentiment
Are you bullish or bearish on NEU?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Mixed / stable
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 65.85%
- Institutions
- 478
- As of
- 2026/Q3 vs. prior period
Holder types
Mutual Fund53.66%
Individual/Insider16.88%
Hedge Fund5.27%
Public Company2.23%
Government Pension Fund2.11%
Private Company1.11%
Sovereign Wealth Fund0.89%
Family Office/Trust0.24%
Government0.13%
Other17.46%
Top holders as of 2026-09-09
Bruce Gottwald
10.07% · 926.34K sh
BlackRock
7.65% · 703.12K sh
The London Company of Virginia, LLC
5.31% · 488.48K sh
Vanguard Portfolio Management, LLC
4.52% · 416.06K sh
Vanguard Capital Management, LLC
4.32% · 397.08K sh
Thomas Gottwald
3.99% · 367.05K sh
Boston Partners Global Investors, Inc.
3.52% · 323.90K sh
AQR Capital Management
2.93% · 269.00K sh
LSV Asset Management
2.59% · 237.76K sh
Bruce Hazelgrove
2.57% · 236.36K sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 24 buys · 25 sells
| Name | Role | Stake |
|---|---|---|
| Bruce Gottwald | Director | 10.07% |
| Thomas Gottwald | Chairperson & CEO | 3.99% |
| Bruce Hazelgrove | Executive Vice President | 2.57% |
| Brian Paliotti | President of Afton Chemical Corporation | 0.07% |
| Mark Gambill | Independent Director | 0.05% |
| James Rogers | Independent Director | 0.04% |
| Bryce Jewett | General Counsel | 0.03% |
| H. Harris | Independent Director | 0.02% |
| Timothy Fitzgerald | Vice President | 0.01% |
| Ting Xu | Independent Director | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-08 | Bruce Gottwald | Director | Other Disposition | -132 | -- |
| 2026-06-30 | H. Harris | Independent Director | Other Acquisition | +157 | -- |
| 2026-06-30 | Mark Gambill | Independent Director | Other Acquisition | +157 | -- |
| 2026-06-30 | James Rogers | Independent Director | Other Acquisition | +157 | -- |
| 2026-06-30 | Ting Xu | Independent Director | Other Acquisition | +157 | -- |
| 2026-06-30 | Lowell Ukrop | Director | Other Acquisition | +157 | -- |
| 2026-06-17 | Thomas Gottwald | Chairperson & CEO | Other Disposition | -211 | -- |
| 2026-06-03 | Thomas Gottwald | Chairperson & CEO | Other Disposition | -1,500 | -- |
| 2026-02-23 | Ting Xu | Independent Director | Open Market Acquisition | +400 | $619.21 |
| 2026-02-18 | Timothy Fitzgerald | Vice President | Sale to Issuer | -34 | $607.04 |
| 2026-02-17 | Bruce Gottwald | Director | Other Disposition | -3,000 | -- |
| 2026-02-17 | Thomas Gottwald | Chairperson & CEO | Other Acquisition | +2,160 | -- |
| 2026-02-17 | Thomas Gottwald | Chairperson & CEO | Other Disposition | -1,320 | -- |
| 2026-02-04 | Thomas Gottwald | Chairperson & CEO | Sale to Issuer | -203 | $714.88 |
| 2026-02-04 | Thomas Gottwald | Chairperson & CEO | Other Acquisition | +655 | -- |
| 2026-02-04 | Bruce Hazelgrove | Executive Vice President | Sale to Issuer | -153 | $714.88 |
| 2026-02-04 | Bruce Hazelgrove | Executive Vice President | Other Acquisition | +475 | -- |
| 2026-02-04 | Bryce Jewett | General Counsel | Sale to Issuer | -136 | $714.88 |
| 2026-02-04 | Bryce Jewett | General Counsel | Other Acquisition | +415 | -- |
| 2026-02-04 | Brian Paliotti | President of Afton Chemical Corporation | Sale to Issuer | -171 | $714.88 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 05:23:50 · For reference only, not investment advice and not tailored to your situation.